The bill mandates the Board of Medicine to revise the standards of practice for prescribing certain pain medications, specifically opioids and controlled substances in schedule I. It requires that before a physician issues an initial prescription or a third prescription in a treatment course for acute or chronic pain, they must discuss with the patient, or their parent or guardian if the patient is a minor, several critical points. These include the risks of addiction and overdose, the necessity of the prescription, alternative treatment options, and the specific risks associated with opioid use, including the potential for dependence and fatal respiratory depression when mixed with other substances.

Additionally, the physician is required to document this discussion in the patient's medical record. However, the bill specifies that these requirements do not apply to prescriptions for patients in advanced stages of cancer or terminal illness where the focus is on comfort care, nor to medications prescribed for treating substance use disorder or opioid dependence.